JP2020509095A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509095A5
JP2020509095A5 JP2019569659A JP2019569659A JP2020509095A5 JP 2020509095 A5 JP2020509095 A5 JP 2020509095A5 JP 2019569659 A JP2019569659 A JP 2019569659A JP 2019569659 A JP2019569659 A JP 2019569659A JP 2020509095 A5 JP2020509095 A5 JP 2020509095A5
Authority
JP
Japan
Prior art keywords
acid
preparation according
formulation
cancer
lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019569659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020509095A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/020797 external-priority patent/WO2018161054A1/en
Publication of JP2020509095A publication Critical patent/JP2020509095A/ja
Publication of JP2020509095A5 publication Critical patent/JP2020509095A5/ja
Priority to JP2023045166A priority Critical patent/JP2023088988A/ja
Pending legal-status Critical Current

Links

JP2019569659A 2017-03-03 2018-03-02 改善された安定性を有する製剤 Pending JP2020509095A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023045166A JP2023088988A (ja) 2017-03-03 2023-03-22 改善された安定性を有する製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762466955P 2017-03-03 2017-03-03
US62/466,955 2017-03-03
PCT/US2018/020797 WO2018161054A1 (en) 2017-03-03 2018-03-02 Formulations with improved stability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023045166A Division JP2023088988A (ja) 2017-03-03 2023-03-22 改善された安定性を有する製剤

Publications (2)

Publication Number Publication Date
JP2020509095A JP2020509095A (ja) 2020-03-26
JP2020509095A5 true JP2020509095A5 (cg-RX-API-DMAC7.html) 2021-04-08

Family

ID=61692107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019569659A Pending JP2020509095A (ja) 2017-03-03 2018-03-02 改善された安定性を有する製剤
JP2023045166A Pending JP2023088988A (ja) 2017-03-03 2023-03-22 改善された安定性を有する製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023045166A Pending JP2023088988A (ja) 2017-03-03 2023-03-22 改善された安定性を有する製剤

Country Status (10)

Country Link
US (2) US11629118B2 (cg-RX-API-DMAC7.html)
EP (1) EP3589280B1 (cg-RX-API-DMAC7.html)
JP (2) JP2020509095A (cg-RX-API-DMAC7.html)
KR (2) KR102641778B1 (cg-RX-API-DMAC7.html)
CN (2) CN110494415A (cg-RX-API-DMAC7.html)
AU (1) AU2018226879B2 (cg-RX-API-DMAC7.html)
CA (1) CA3054948C (cg-RX-API-DMAC7.html)
ES (1) ES2975417T3 (cg-RX-API-DMAC7.html)
MX (1) MX394833B (cg-RX-API-DMAC7.html)
WO (1) WO2018161054A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2975417T3 (es) * 2017-03-03 2024-07-05 Inspirna Inc Formulaciones con estabilidad mejorada
EP3713575A4 (en) 2017-11-21 2021-08-25 Rgenix, Inc. POLYMORPHS AND THEIR USES
JP7689964B2 (ja) 2019-12-13 2025-06-09 インスピルナ,インコーポレーテッド 金属塩及びその使用
AU2022248850A1 (en) 2021-03-27 2023-11-09 TRx Biosciences Limited Compositions having improved bioavailability of therapeutics
AU2023233811A1 (en) * 2022-03-14 2024-09-19 TRx Biosciences Limited Compositions having improved bioavailability of therapeutics and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3102078A (en) 1961-01-13 1963-08-27 Eastman Kodak Co Water-dispersible vitamin preparations
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6884060B2 (en) 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
AU2003226094A1 (en) 2002-03-27 2003-10-13 Smithkline Beecham Corporation Compounds and methods
JP2005521721A (ja) 2002-03-27 2005-07-21 スミスクライン・ビーチャム・コーポレイション 酸およびエステル化合物ならびにその使用方法
US7323494B2 (en) 2002-03-27 2008-01-29 Smithkline Beecham Corporation Compounds and methods
EP1497270A4 (en) 2002-03-27 2006-01-04 Smithkline Beecham Corp AMID COMPOUNDS AND METHOD FOR THEIR USE
US20040219274A1 (en) 2003-04-29 2004-11-04 Cook Phillip Michael Beverages containing water-soluble vitamin E
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
CN101232871A (zh) 2005-08-03 2008-07-30 伊士曼化工公司 生育酚聚乙二醇琥珀酸酯粉末及其制备方法
WO2014028461A2 (en) * 2012-08-13 2014-02-20 The Rockefeller University Treatment and diagnosis of melanoma
AU2015204572B2 (en) * 2014-01-10 2020-07-30 Inspirna, Inc. LXR agonists and uses thereof
WO2016100619A2 (en) * 2014-12-17 2016-06-23 Rgenix, Inc. Treatment and diagnosis of cancer
ES2975417T3 (es) * 2017-03-03 2024-07-05 Inspirna Inc Formulaciones con estabilidad mejorada

Similar Documents

Publication Publication Date Title
JP2023088988A5 (cg-RX-API-DMAC7.html)
JP6697779B2 (ja) カルシフェジオール軟カプセル剤
JP2012526094A5 (cg-RX-API-DMAC7.html)
US11116744B2 (en) Pharmaceutical composition for oral administration comprising taxane
TWI654981B (zh) 包含度他雄胺和丙二醇單月桂酸酯的醫藥組成物及其製備方法
JP2015516418A5 (cg-RX-API-DMAC7.html)
US20250188018A1 (en) Formulations with improved stability
JP2018515463A5 (cg-RX-API-DMAC7.html)
KR101767296B1 (ko) 활성제로서 페닐아미노피리미딘 유도체를 포함하는 제제
JP2024505630A5 (cg-RX-API-DMAC7.html)
JP6247118B2 (ja) カプセル充填組成物
JP2019513828A5 (cg-RX-API-DMAC7.html)
TWI552772B (zh) 包含11-去氧-前列腺素化合物之醫藥組成物及使該化合物安定化之方法
JP2019505571A5 (cg-RX-API-DMAC7.html)
HK40034919A (en) Calcifediol soft capsules
HK40034919B (en) Calcifediol soft capsules
HK1235289A1 (en) Calcifediol soft capsules